International Journal of Medical Sciences

Impact factor
2.399

23 October 2017

ISSN 1449-1907 News feeds of published articles

My Manuscript | My Account

Journal of Genomics now in PubMed/PubMed Central. Submit manuscript...

Journal of Biomedicinenew

Theranostics

Journal of Cancer

Oncomedicine

International Journal of Biological Sciences

Journal of Genomics

Journal of Bone and Joint Infection (JBJI)

Nanotheranostics

PubMed Central Indexed in Journal Impact Factor

Int J Med Sci 2013; 10(6):719-729. doi:10.7150/ijms.5037

Research Paper

Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral Peptides

Mohammed Abdelfatah Alhoot1, 2, Alwin Kumar Rathinam3, Seok Mui Wang4, Rishya Manikam5, Shamala Devi Sekaran1✉

1. Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Lembah Pantai, 50603 Kuala Lumpur, Malaysia;
2. Department of Medical Microbiology, International Medical School, Management & Science University, Shah Alam, 40100, Selangor, Malaysia;
3. Virtual Reality Centre/ Centre for Biomedical Technology Intergration Pte Ltd, University of Malaya, 50603 Kuala Lumpur, Malaysia;
4. Institute of Medical Molecular Biotechnology, Faculty of Medicine, Universiti Teknologi Mara, Selangor, Malaysia;
5. Department of Trauma and Emergency Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Abstract

Despite the importance of DENV as a human pathogen, there is no specific treatment or protective vaccine. Successful entry into the host cells is necessary for establishing the infection. Recently, the virus entry step has become an attractive therapeutic strategy because it represents a barrier to suppress the onset of the infection. Four putative antiviral peptides were designed to target domain III of DENV-2 E protein using BioMoDroid algorithm. Two peptides showed significant inhibition of DENV when simultaneously incubated as shown by plaque formation assay, RT-qPCR, and Western blot analysis. Both DET4 and DET2 showed significant inhibition of virus entry (84.6% and 40.6% respectively) using micromolar concentrations. Furthermore, the TEM images showed that the inhibitory peptides caused structural abnormalities and alteration of the arrangement of the viral E protein, which interferes with virus binding and entry. Inhibition of DENV entry during the initial stages of infection can potentially reduce the viremia in infected humans resulting in prevention of the progression of dengue fever to the severe life-threatening infection, reduce the infected vector numbers, and thus break the transmission cycle. Moreover these peptides though designed against the conserved region in DENV-2 would have the potential to be active against all the serotypes of dengue and might be considered as Hits to begin designing and developing of more potent analogous peptides that could constitute as promising therapeutic agents for attenuating dengue infection.

Keywords: Dengue virus, Antiviral peptides, Inhibitory Peptides, Viral entry, Envelope protein, Domain III

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD. Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral Peptides. Int J Med Sci 2013; 10(6):719-729. doi:10.7150/ijms.5037. Available from http://www.medsci.org/v10p0719.htm